Photothermal Effect Enhanced Cascade-Targeting Strategy for Improved Pancreatic Cancer Therapy by Gold

Ruifang Zhao1,2,3, Xuexiang Han1,2,3, Yiye Li1,3

  • 1CAS Key Laboratory for Biomedical Effects of Nanomaterials and Nanosafety, CAS Center of Excellence in Nanoscience, National Center for Nanoscience and Technology , Beijing 100190, P. R. China.

ACS Nano
|July 26, 2017
PubMed

Insights

Gold nanoshell-coated rod-like mesoporous silica (GNRS) nanoparticles enhance gemcitabine chemotherapy for pancreatic cancer. This novel nanoformulation overcomes treatment resistance by improving drug delivery and tumor targeting.

Area of Science:

  • Biomedical Engineering
  • Nanotechnology
  • Oncology

Background:

  • Pancreatic cancer has a high mortality rate due to treatment resistance.
  • Desmoplasia and hypovascularity contribute to poor therapeutic outcomes.
  • Conventional therapies show limited efficacy, with a 5-year survival rate below 8%.

Purpose of the Study:

  • To develop an integrated nanoformulation for enhanced pancreatic cancer treatment.
  • To combine cascade tumor targeting and photothermal treatment-enhanced chemotherapy.
  • To overcome the dense stroma barrier and improve gemcitabine delivery.

Main Methods:

  • Synthesis of gold nanoshell-coated rod-like mesoporous silica (GNRS) nanoparticles.
  • Integration of photothermal effect and molecular receptor binding for tumor targeting.
  • Application of mild near-infrared laser irradiation for photothermal therapy and drug release.
  • Evaluation of gemcitabine penetration, accumulation, and therapeutic efficacy in preclinical models.

Main Results:

  • GNRS nanoparticles demonstrated effective cascade tumor targeting.
  • The photothermal effect enhanced gemcitabine penetration and accumulation in tumor tissues.
  • The dense stroma barrier of pancreatic cancer was disrupted.
  • Chemosensitivity was significantly reinforced in treated mice.

Conclusions:

  • The integrated plasmonic photothermal strategy shows promise for pancreatic cancer treatment.
  • GNRS nanoparticles offer enhanced drug delivery efficacy and overcome therapeutic resistance.
  • This nanoformulation represents a potential translational approach for effective pancreatic cancer therapy.